Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hypertension Clinical Trial Pipeline Report 2019 - ResearchAndMarkets.com

June 10, 2019

DUBLIN--(BUSINESS WIRE)--Jun 10, 2019--

The “Global Hypertension Clinical Trial Pipeline Highlights - 2019” report has been added to ResearchAndMarkets.com’s offering.

Hypertension Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Hypertension market. It covers emerging therapies for Hypertension in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Hypertension pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Hypertension pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.


The report provides Hypertension pipeline products by the company.

Short-term Launch Highlights:

Find out which Hypertension pipeline products will be launched in the US and Ex-US to 2024.


Key Topics Covered:

1. Hypertension Pipeline by Stages

2. Hypertension Phase 3 Clinical Trial Insights

3. Hypertension Phase 2 Clinical Trial Insights

4. Hypertension Phase 1 Clinical Trial Insights

5. Hypertension Preclinical Research Insights

6. Hypertension Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/5twh58

View source version on businesswire.com:https://www.businesswire.com/news/home/20190610005642/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs ,Clinical Trials



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 06/10/2019 02:02 PM/DISC: 06/10/2019 02:02 PM


All contents © copyright 2019 The Associated Press. All rights reserved.